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Age related muscle wasting leads to overall reductions of lean body mass, reduced
muscle strength, and muscle function resulting in compromised quality of life. Utilizing
novel nutritional strategies to attenuate such losses is of great importance in elderly
individuals. We aimed to test if a complete dietary supplement containing 25 g of milk
proteins and ingested in the evening before bed would improve protein metabolism in
terms of whole body protein balance over a 10 h overnight period following ingestion of
the test drink in healthy middle-aged male subjects. In addition we also assessed the
rates of muscle protein synthesis during the second half of the night in order to see
if previously reported extended amino acidemia during sleep results in increased rates
of muscle protein synthesis. Seventeen healthy middle-aged male subjects (59.4 ± 3.2
year) consumed a dietary supplement drink at 21:00 containing either 25 g milk protein
concentrate, 25 g maltodextrin, 7.75 g canola oil (treatment group), or an isocaloric
protein void drink (placebo group). Muscle protein synthesis was assessed from amuscle
biopsy following the continuous intravenous infusion of 13C-phenylalanine for 5 h (from
03:00 to 08:00). Whole body protein balance was greater in the treatment group (−0.13
± 11.30 g prot/10 h) compared to placebo (−12.22 ± 6.91 g prot/10 h) (P ≤ 0.01). In
contrast, no changes were observed on rates of muscle protein synthesis during the
second half of the night. Ingestion of a dietary supplement containing 25 g of milk proteins
significantly reduced the negative protein balance observed during the night. Therefore,
pre-bedtime protein ingestion may attenuate overnight losses of lean tissue in healthy
elderly men. Despite increases in aminoacidemia during the second part of the night, no
changes were observed in the rates of muscle protein synthesis during this time.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT02041143.
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INTRODUCTION
Skeletal muscle is the most abundant tissue in the human body
and plays a key role in both locomotion and metabolic health
and it is therefore important to maintain healthy muscle mass
and function as we age (1). Two triggers known to stimulate
adaptations in skeletal muscle include nutrition (macro- and
micro-nutrients) (2–5) and contractile activity (weight loading
and unloading) (1, 6–9). Repeated exposure to such stimuli over
time initiate changes at the molecular level allowing skeletal
muscle to adapt and alter its profile to meet the demands of
its new environment (10). This regulation of skeletal muscle
protein turnover is primarily coordinated by changes in the rates
of both muscle protein synthesis (MPS) and muscle protein
breakdown (MPB). However, with the progression of age, the rate
of muscle protein turnover and especially the lower postprandial
MPS response may contribute to a reduction in muscle mass
and function (11). Specifically, at a population level it has been
demonstrated that after the fifth decade of life muscle mass
is reduced by ∼1% per year (12). This accumulated loss of
muscle mass over time may lead to mobility limitations in older
individuals (13).
Fasting, such as that observed during overnight sleep, results
in negative muscle protein balance as a result of both, reduced
rates of muscle protein synthesis and increased rates of muscle
protein breakdown (9, 14–16). Nutritional strategies aimed
at maintaining and improving lean tissue body composition
may be beneficial for elderly populations who are at risk of
muscle atrophy and accelerated muscle loss as observed under
sarcopenic conditions. Therefore, attenuating the overnight
losses of lean tissue mass (including muscle) would potentially
be beneficial in helping maintain lean tissue/muscle mass in
the elderly. Several bodies of work have addressed this proof
of concept in young, healthy, physically active subjects which
have been reviewed in recent work by Trommelen and Van
Loon (17). Specifically, Res et al., reported that 25 g post-
exercise (21:30) whey protein ingestion followed by a second 40 g
bolus ingestion of casein at 23:30 (before bed time) resulted in
increased muscle protein balance over an 8-h period in young
healthy male subjects (18). In addition, the authors reported that
plasma amino acid concentrations remained elevated throughout
the sleep duration highlighting a potential extension in the
nutrient driven anabolic state. More recently, Kouw et al. (19)
showed that the ingestion of 40 g protein before sleep increased
myofibrillar protein synthesis during overnight sleep. This effect
was not observed after ingestion of 20 g protein. However, what
is not clear is whether or not the increased whole body protein
balance observed in the morning was due to an extension in the
postprandial anabolic window beyond that normally observed
(within 3–5 h postprandialy). Moreover, it is not known if such
a benefit would be observed in older individuals following the
ingestion of a complete oral nutritional supplement containing
25 g of dairy protein together with carbohydrate and fat.
Therefore, the aim of the present study was to investigate if
whole body nitrogen balance would be improved after ingestion
of a complete oral nutritional supplement (25 g milk protein, 25 g
maltodextrin, and 7.5 g canola oil) in healthy elderly individuals.
In addition we aimed to identify if there is an extension to the
anabolic window of opportunity for muscle protein synthesis
beyond the commonly reported 3–5 h postprandial window due
to increased amino acid availability.
SUBJECTS AND METHODS
Subject Characteristics
A total of 17 healthy recreationally active men aged 59.4 ± 3.2
year (range: 55–66 year) were selected to participate in this study
(Figure 1). Subjects were recruited locally, through a recruitment
agency (TrialReach, Nyon, Switzerland). Inclusion criteria were
healthy males aged 50–70, with a BMI between 19.0 and 27.0
kg/m2. Main exclusion criteria were any cardiovascular disease
including arterial hypertension, any clotting disorders or any
chronic intake of medications jeopardizing clotting, participation
in any special diet (vegan, vegetarian, high protein intake) or
weight loss program, food allergies, medication for chronic
disease or any people following a strict exercise regime in order
to either lose weight, gain muscle or reach competition standards
for a chosen sport. The study was approved by the Commission
Cantonale d’Ethique (VD) pour la Recherche sur l’Etre Humain,
Switzerland, under the reference 423/13.
Subjects were randomly assigned to either the protein
containing supplement (PRO: n = 9) or an isocaloric protein
void placebo supplement (PLA: n = 8) experimental group. One
individual in the PLA experiment group had to be excluded
because it was not possible to obtain the muscle biopsy. Subject
characteristics are presented in Table 1. All subjects were fully
informed on the nature and possible risks of the experimental
procedures before their written informed consent was obtained.
Before taking part, all subjects underwent routine medical
screening and eligible participants all gave their informed signed
consent to take part in the study and were aware that they were
free to withdraw from the experiment at any point.
Experimental Design
A detailed schema outlining the study procedure is described in
Figure 2.
Eligible subjects reported to the Nestlé Metabolic Unit in the
morning of the experimental day at 07:30 having fasted from
22:00 the preceding evening. A fasted blood sample was obtained
in order to measure blood clotting parameters (prothrombin
time, activated partial thromboplastin time, and fibrinogen).
Each subject was provided with a standardized breakfast which
was consumed on site. Subsequently, each subject was provided
with a standardized lunch and advised to consume it at 12:00. All
subjects reported back to the Nestlé Metabolic Unit at 17:30 and
were provided with a standardized dinner which was consumed
at 18:00. Subjects were not controlled for snacks out of the
laboratory but they were asked to refrain from consuming protein
supplements in the 15 days preceding the testing session. The
total amount of protein in each of the standardized meals was
defined as 1.2 g protein per kg of body weight. For practical
reasons, 1 meal portion was designed to contain 61.15 g of
protein (chicken breast) and subjects were given 1, 1.25, 1.5,
or 1.75 portions as a function of their body weight. Following
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FIGURE 1 | CONSORT flow diagram of the study.
completion of the dinner meal, two catheters were inserted into
an antecubital vein.
Prior to the ingestion of the tracer at 21:00 subjects voided
their bladder. Subsequently, a blood sample was obtained
and used for baseline measurements of plasma amino acids,
glucose and insulin. Following this and 15min before the
commencement of the experimental trial, each subject ingested
the intervention supplement (at 21:00) containing 200mg of
[15N]glycine stable isotope tracer (Euriso-top, St. Aubin, France).
The intervention product contained either 3.1% canola oil,
10% maltodextrin DE21, and 10% milk protein concentrate
(test product) or 3.1% canola oil, and 20% maltodextrin DE21
(placebo). Both products were isocaloric with a total calorie
content of 270 kcal per drink (test product). Each subject in each
group was required to consume 250 g of either the study test
product or placebo. Each subject remained in a resting condition
for 2 h before going to bed (23:00 h) for an 8-h sleep period.
At 03:00 the plasma phenylalanine pools were primed
with a single intravenous dose of [13C6]phenylalanine
(2.0µmol/kg). Thereafter, a continuous stable isotope infusion of
[13C6]phenylalanine (Euriso-top, St. Aubin, France) was initiated
at an infusion rate of 0.050 µmol kg−1 min−1 for 300min. At
the end of the infusion (t = 8.00 h) a muscle biopsy was obtained
from the vastus lateralis muscle under local anesthesia (see
Figure 2). During the infusion of the [13C6]phenylalanine,
arterialized blood samples were obtained to confirm steady
state conditions.
Blood samples were obtained at specific time points
throughout the night (−15min before drink ingestion and 1,
3, 6, 7, 10, and 11 h following drink ingestion) without waking
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the subjects. Urine was collected once the subjects had woken
or during toilet breaks during the night. Subjects woke up at
07:00. Following the muscle biopsy procedure, each subject was
provided with a standard breakfast.
Muscle Biopsy
Muscle biopsies were performed according to the Bergstrom
methodology. Briefly, local anesthesia [2–3ml of 1% xylocain
(rapidocain R©)] was administered to the skin, subcutaneous tissue
and fascia of the vastus lateralis in preparation for muscle
sampling. A muscle biopsy sample (100–150mg) of the Vastus
lateralis was obtained using a 5mm Bergstrom needle with
manual suction by an experienced practitioner. The muscle
sample was then washed and immediately frozen in liquid
nitrogen and stored at−80◦C for further analysis.
Whole Body Protein Balance
Whole body protein turnover was calculated using the end-
product method as described previously (20). The 15N isotopic
enrichments of urinary ammonia and urea samples were
determined in duplicate after isolation of both components
by cation exchange resin (Bio-Rad AG, Reinach, Switzerland)
TABLE 1 | Baseline characteristics of participants.
Placebo
(n = 8)
Treatment
(n = 9)
p (t-test)
Age (years) 60.4 ± 3.02 57.9 ± 2.93 0.11
Height (cm) 181 ± 7.33 178 ± 7.38 0.55
Weight (kg) 79.6 ± 9.59 76.1 ± 9.85 0.46
BMI (kg/m2 ) 24.4 ± 1.47 23.8 ± 1.64 0.48
Diastolic blood pressure (mmHg) 82.6 ± 5.10 80 ± 8.40 0.44
Systolic blood pressure (mmHg) 135 ± 5.98 125 ± 8.82 0.03*
Values are means ± SD. For comparison of numerical values, statistics were obtained
with the use of Student’s t-test.
*Different from controls (P < 0.05).
and measured by isotope ratio mass spectrometry (Delta V
coupled to an elemental analyzer, Thermo Fischer, Bremen,
Germany). Concentrations of urinary urea and creatinine,
the major nitrogen containing metabolites in urine, were
measured by an automated analyzer (Cobas, Hoffmann- La
Roche, Switzerland). Isotopic enrichments were expressed as
TTR (tracer to tracee ratio) corrected from baseline isotopic
enrichment. Whole body nitrogen turnover (Q) was calculated
as Q (mg N/kg/h) = d/Ei/BW/time; where d is the dose of oral
[15N]glycine in g, Ei is the isotopic enrichment of 15N ammonia,
t is the time of urine collection (i.e., 10 h) and BW is the body
weight expressed in kg (21). Whole body protein synthesis (S)
and whole body protein breakdown B were then calculated from
the expression Q = S + E = B + I; where E is the excretion of
nitrogen estimated as the sum of urea and creatinine excretion
plus other losses (i.e., fecal and miscellaneous). Protein synthesis
and protein breakdown were normalized by body weight (BW)
and finally expressed as mg protein/kg BW/h (using 6.25 as
coefficient to transform nitrogen to protein fluxes).
Muscle Protein Synthesis
Mixed muscle fractional synthesis rate (FSR) were based on
the single biopsy approach (22, 23). FSR (expressed in %/h)
was calculated using the standard precursor-product equation
(validated for a single muscle biopsy approach) as described by
Burd et al. (23).
FSR(%/h) = (Ep2 − Ep1)/Eic/t× 100;
Where, Ep2 and Ep1 are the
13C isotopic enrichment of Phe
from protein bound in muscle (from the muscle biopsy) and Phe
from plasma protein, respectively. Eic is the mean intracellular
phenylalanine enrichment from the biopsy and t is the tracer
incorporation time.
FIGURE 2 | Study overview for the measurement of the effect of pre-bedtime dietary protein intake and its effect on whole body protein balance and rates of muscle
protein synthesis. A drink containing 25 g of milk protein concentrate was ingested at 21:00 h. For the measurement of muscle protein synthesis a tracer
([13C6]phenylalanine) infusion was commenced at 03:00 h and a single muscle biopsy was obtained 5 h later at 08:00 h.
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Sample Collection, Processing, and
Analysis for FSR Determination
Blood samples were collected in pre-chilled tubes containing
EDTA. Plasma was separated by centrifugation and then stored
at −80◦C until analysis. Muscle samples were rinsed in ice-cold
saline solution immediately after collection, then cleared from fat
tissues and finally frozen in liquid nitrogen.
To determine plasma 13C Phe isotopic enrichment expressed
as tracer-to-tracee ratio (TTR), plasma was precipitated
with acetonitrile and free amino acids were derivatized by
preparing propyl-chloroformate derivatives and analyzed using
Phenomenex ZB-AAA column (15m × 0.25mm, 0.1µm
I.D film thickness column, from Brechbuller, Switzerland).
Plasma Phe TTR were monitored by gas chromatography/mass
spectrometry (GC-MS, MSD 5973 System, Hewlett Packard).
13C isotopic enrichment of Phe from plasma protein and
muscle protein (biopsy samples) were determined using a gas
chromatography-combustion-isotope ratio mass spectrometry
(Delta V Hyphenated to GC system from Thermo Fischer,
Bremen, Germany). Isotopic data (13C/12C ratio) were expressed
in delta per mil value (δ13C, ‰). The pellets containing muscle
and plasma proteins was washed and then hydrolyzed with 6N
HCL at 110◦C for 24 h. Amino acids obtained were then purified
on cation exchange chromatography (Dowex 50W-X8-200, Bio-
Rad Laboratories), then derivatized to get N-acetyl-n-propyl ester
derivative (NAP) amino acid and analyzed on DB5-MS column
(30m × 0.25mm; 0.25µm I.D film thickness column, from
Agilent, Germany).
For FSR calculation, in this study, background 13C-Phe
enrichment of mixed plasma proteins for the initial isotopic
enrichment as described by Burd et al. and intracellular 13C-Phe
(as precursor pool) were used. We found that the plasma protein
measured before administration of the tracer was δ13C=−32.49
± 0.52 ‰ (n = 17, expressed as mean ± SD) showing a good
repeatability between subjects. Like in most of the studies with
13C-Phe as tracer, we used muscle intracellular free 13C-Phe as
precursor (24). Internal validation of this single biopsy approach
showed an analytical intra-day repeatability (n = 6 days) of FSR
of 6%.
Plasma Amino Acid Analysis
Within 30min following blood sampling, the samples were
centrifuged at 1,800 g for 20min at +4◦C (3,200 rpm). About
500 µl of the supernatant were transferred into a fresh 1.5mL
Eppendorf tube and frozen at−80◦C.
Samples were thawed and then work on ice at ∼4◦C. The
samples were centrifuged for 1min at 8,000 rpm at 4◦C. The
200 µl aliquot was then transferred to a fresh Eppendorf tube.
While vortexing, 20 µl of ice cold (2–8◦C) sulfosalycilic acid
40% solution were added to the plasma aliquot. This was then
vortexed for 1min at 1,800 rpm. The samples were then kept
between 2 and 8◦C for 15min before centrifuging for 3min at
13,000 g at 4◦C.
Individual amino acid concentrations were measured by ion
exchange chromatography with spectrophotometer detection
after ninhydrine derivatization using and Amino Acid Analyser
(Biochrom 30, Onken, Germany). The sum of all individual
AA measured provided the total of plasma amino acids
concentration. The sum of all individual essential AA’s measured,
provided the essential plasma AA concentration.
Western Analysis of AKT/p70S6k Signaling
Proteins
Western blot analysis was performed using the NuPage
System precast gels as described by the manufacturer (Novex,
Life Technologies). About 40mg of frozen muscle tissue was
homogenized in ice cold lysis buffer A (50 mmol/L Tris-HCL, pH
7.5, 1 mmol EDTA/L, 1 mmol EGTA/L, 10%glycerol, 1%triton-X,
50 mmol NaF/L, 5 mmolNa4P2O7/L, 1 mmol dithiothreitol/L,
10mg trypsin inhibitor/mL, 2mg aprotinin/mL,1 mmol
benzamidine/L, and 1 mmol phenylmethylsulfonylfluoride/L)
using a TissueLyser (Qiagen). The lysate was centrifuged (12,000
× g, for 20min at 4◦C) and the supernatant was transferred
to fresh Eppendorf tubes for subsequent quantification of
protein content. The protein concentration for each muscle
extract was determined using the Pierce BCA Protein Assay
Kit (Thermo Scientific). Equal amounts (5 µg) of protein
samples were denatured by boiling for 5min. Subsequently,
samples were loaded onto 4–12% Bis-Tris midi gels before
being transferred onto nitrocellulose membranes (iBlot gel
Transfer Stacks, Life Technologies) and blocked for 1 h with
Odyssey Blocking Buffer at room temperature. Each membrane
was then incubated overnight at 4◦C with a primary antibody
[Anti-AKT1 phospho (1:2,000) ab66138; Anti-rpS6 (1:1,000)
ab40820; Anti-AKT1 (1:1,000) ab91505 were purchased from
Abcam; Phospho-p70S6K (1:500) #9205; Phospho-rpS6 (1:1,000)
#2211; Phospho mTOR (1:500) #2971; mTOR (1:1,000) #2972;
α-Tubulin (1:1,000) #3873 were purchased from Cell Signaling
Technology], diluted in 0.1% Tween Odyssey Blocking Buffer
PBS (LI-QOR Biosciences). The following morning each
membrane was washed with PBS containing 0.1% Tween 20
(PBST). The membranes were then incubated for 1 h at room
temperature in a black box with IRDye800CW-conjugated
goat anti-rabbit or anti-mouse secondary antibodies (LI-COR
Biosciences) diluted in Odyssey Blocking Buffer. The blots
were then washed four times with PBST and rinsed with PBS.
Proteins were visualized by scanning the membrane on an
Odyssey Infrared Imaging System (LI-COR Biosciences) with
800-nm channels.
Insulin and Glucose Analysis
Insulin
Plasma insulin concentrations was measured using the
commercially available IBL Insulin Enzyme Immunoassay
Kit (IBL International) according to manufacturer’s directions.
Glucose
Plasma glucose concentrations were assessed using the Siemens
dimension EXL 200 clinical chemistry system (Siemens
Healthcare Diagnostics AG, Zurich, Switzerland).
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Statistical Analysis
No sample size calculation have been performed due to absence
of data on mean difference and variations of endpoints in
this study.
Endpoints with a single measure (changes in whole body
protein, FSR, signaling pathways and other variables) -were
analyzed using a paired t-test or a Wilcoxon rank-sum test,
depending on the presence of outliers (outliers were defined
as value exceeding the distance from the mean by more than
two standard deviations). For parameters with longitudinal
measurements, a two-way ANOVA with repeated measurements
was employed to test the treatment effect over time and its
interaction with time. Pairwise comparisons at different time
points were only evaluated in the case when the overall treatment
effect was statistically significant. These rules were agreed upon
in the statistical analysis plan prior to unblinding of the study.
In addition, for data with 5 time points, mean profile of
insulin, glucose and amino acids was estimated using spline
and summarized by an AUC. Estimates of tmax (time where
concentration is maximum), Cmax (value of the maximum
concentration), AUC (area under the curve), and AUCc (area
under the curve, corrected for baseline value) were based on 1,000
replicates of themean smoothing curves in each treatment group.
No multiplicity adjustments were performed. Data are expressed
as means ± SDs. Significance was set at α = 0.05. The analyses
were performed in R software (version 3.0.1, R Foundation for
Statistical Computing).
RESULTS
Baseline Characteristics
All participants in both supplementation groups in the present
study had similar baseline values for age and body mass index
(Table 1).
Plasma Amino Acid Concentrations
No treatment effect was observed for either total amino acids,
essential amino acids, branched chain amino acids or leucine
plasma concentrations between groups at baseline. However,
total amino acid plasma concentrations were significantly greater
in the treatment group compared to the placebo group at 1
and 3 h (P < 0.001; Figure 3A). Essential amino acid plasma
concentrations were significantly higher in the treatment group
compared to placebo at 1 h (P < 0.001), 3 h (P < 0.001), 6 h (P <
0.001), and 10 h (P = 0.01) (Figure 3B). Furthermore, branched
chain amino acid plasma concentrations were significantly higher
in the treatment group compared to placebo at 1 h (P < 0.001),
3 h (P < 0.001), 6 h (P < 0.01), and 10 h (P = 0.01) (Figure 3C).
Finally, leucine plasma concentrations were significantly greater
in the treatment group compared to placebo at 1 h (P < 0.001),
3 h (P < 0.001), 6 h (P = 0.01), and 10 h (P = 0.05) (Figure 3D).
Plasma Insulin and Glucose
Concentrations
Plasma insulin and glucose concentrations are presented in
Figures 4A,B, respectively. A treatment effect was observed at
time 1 h for insulin showing a Cmax significantly higher (P <
0.05) in the placebo group compared to treatment (Figure 4B). A
significant difference was observed in the glucose concentrations
between treatments at 1 h (placebo group higher) and 10 h
(treatment group higher) (P < 0.001 and P < 0.05, respectively;
Figure 4B).
Rates of Muscle Protein Synthesis
Plasma free phenylalanine enrichment was significantly different
between pre-administration of the tracer and 1 h after (7 h
post-drink, data not reported). When plotting the average
TTR of free 13C-Ph in plasma over time (7, 10, and 11 h),
the slope was not significantly different from 0 (P = 0.17).
TTR ranged from 0.0702 ± 0.006 at 7 h to 0.0673 ±
0.0082 (n = 17). These data suggest that plasma free 13C-
Ph reached a plateau and subjects were in isotopic steady
state condition throughout the duration of the tracer infusion.
The rates of muscle protein synthesis were measured between
03:00 and 08:00. No significant changes were observed in
the rate of muscle protein synthesis, over time or between
treatments (Figure 5).
Whole Body Protein Balance
The ingestion of the placebo drink resulted in negative whole
body protein balance across the entire 10 h overnight sleep
period (−12.22 g prot/10 h). In contrast, the ingestion of the
protein containing drink resulted in a near zero protein balance
across the entire 10-h overnight sleep period (−0.13 g prot/10 h)
and this difference was significantly different compared to
the placebo group (P < 0.01) (Figure 6). One individual in
the placebo group had to be excluded because it was not
possible to obtain a muscle sample. No significant differences
were observed in either whole body protein synthesis or
breakdown (Figure 6).
Western Analysis of Muscle Signaling
Proteins
Western analysis was carried out on the muscle biopsy
obtained at 08:00. No significant changes were observed
between treatments for any of the signaling proteins
examined (Figure 7).
DISCUSSION
To date, only a few studies have investigated the impact of
pre-bedtime dietary protein ingestion on either whole body or
muscle specific protein turnover and most of this work has been
carried out as part of a resistance exercise training program
in young and elderly healthy physically active individuals
(17, 18, 25–28).
In light of the accelerated loss of lean tissue mass observed
in the elderly (including muscle), nutritional strategies aimed
at preventing such losses are of key importance in such
populations. A recent paper showed that the ingestion of
a 40 g protein bolus before sleep increased muscle protein
synthesis during overnight sleep (19). In our present study,
we report that providing a complete protein containing
drink (containing 25 g of dietary protein together with
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FIGURE 3 | Plasma amino acid concentrations for (A) total (TAA), (B) essential (EAA), (C) branched chain (BCAA), and (D) leucine for control (light bars) and treatment
(dark bars) groups observed over 10 h post supplement ingestion. Supplement was ingested immediately after the first blood sample was obtained. Values are means
± SD. *Significantly different at corresponding time point between groups (P < 0.05).
FIGURE 4 | Plasma (A) Glucose and (B) Insulin concentrations for control (light bars) and treatment (dark bars) groups observed over 10 h post supplement ingestion.
Supplement was ingested immediately after the first blood sample was obtained. Values are means ± SD. *Significantly different at corresponding time point between
groups (P < 0.05).
25 g carbohydrate and 7.5 g oil) to healthy middle-aged
individuals before sleep, prevented the negative whole
body protein balance and that muscle protein synthesis
specifically, is not augmented in the later part of the night despite
elevated aminoacidemia.
Interestingly Res et al., previously reported that a total of
60 g of casein resulted in greater whole body protein balance
and increased muscle protein synthesis in young exercising
participants (18) while Groen et al. showed that nasogastric
feeding of 40 g casein commencing at 02:00 in elderly resulted
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FIGURE 5 | Mixed muscle rates of protein synthesis measured between 03:00
and 08:00 h in control (light bars) and treatment (dark bars) groups. Values are
means ± SD. No significant difference was observed between treatments.
FIGURE 6 | Rates of whole body protein synthesis, breakdown and balance in
control (light bars) and treatment groups (dark bars) observed across the 10 h
overnight sleep duration. Values are expressed as means ± SD. To test the
treatment effect over time, a two-way ANOVA with repeated measurements
was employed. Pairwise comparisons at different time points were only
evaluated in case when overall treatment effect was statistically significant,
*Significantly different from control (P < 0.05).
in normal digestion and absorption kinetics, stimulating muscle
protein synthesis and improved overnight whole body protein
balance (29). In these studies, muscle protein synthesis was
measured over the whole night and thus it is unknown if
the effect observed was related to a stimulation of protein
synthesis occurring all along the night in response to the
sustained amino acid availability or only during the first hours
after protein ingestion (as usually described when a meal effect
is studied).
In our study we still observed amino acid digestion kinetics
similar to those previously reported in individuals throughout
the night. Specifically, we observed substantial elevations in
plasma amino acid concentrations (TAA, BCAA, EAA, Leucine)
throughout the night when compared to the isocaloric, protein
void control drink which is even more extended than previously
reported by Kouw et al. (19) who reported a return to baseline
values about 6 h following the ingestion of 20 g whey protein.
In our study, we still observed higher aminoacidemia values
in the treatment group after 10 h which may in part be due
FIGURE 7 | Relative phosphorylation status of proteins involved in skeletal
muscle protein synthesis for AKT, mTOR, p70S6K, and rpS6. Values are
expressed as means ± SD and are expressed as the ratio between
phosphorylated forms to total protein and corrected for a house keeper. No
significant differences were observed for any of the proteins between
treatments.
to either a slower digestion rate related to the presence of
carbohydrate and fat in our treatment drink, the additional 5 g
of protein provided in our treatment drink or a combination
of both. Moreover, given that muscle protein synthesis is only
stimulated for several hours following an increase in plasma
amino acid concentrations (5, 30, 31) it is not clear if the observed
benefits in whole body protein balance in our study as well
as the increased rates of muscle protein synthesis and whole
body net protein balance observed previously by others were
driven at specific time points (0–4 h following protein ingestion)
or across the whole duration of the night (extended amino
acid availability).
Accordingly, Kouw et al. concluded that the greater plasma
amino acid availability they observed following 40 g of protein
ingestion compared to 20 g during the longer overnight period
may have been required in order to allow a measurable
increase in muscle protein synthesis rates. To address this
question we assessed muscle protein synthesis at the later
part of the night between the hours of 03:00–08:00. Despite
the extended increases in plasma amino acid concentrations
observed in our study (Figure 3) we found that rates of
muscle protein synthesis at the later part of the night did
not differ between groups. In addition we also quantified
the activation of the canonical signaling cascade implicated
in skeletal muscle protein synthesis and found no significant
differences between treatment groups for either AKT, mTOR,
rpS6, or p70S6K (Figure 7). In light of these observations,
it seems therefore that the observed increase in whole body
protein balance in our study was most likely driven by the
immediate postprandial response to the beverage ingestion (first
4 h post-ingestion).
What is not clear however, is why the extended and elevated
amino acid plasma concentrations did not stimulate muscle
protein synthesis. One possibility is that the threshold plasma
levels of circulating amino acids required to stimulate muscle
protein synthesis was not reached. Indeed, when we compared
the activation of the mTOR signaling pathway in the morning
at waking we did not observe any changes between treatments
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in relative phosphorylation of either mTOR, rpS6, or p70S6K
which are known to be activated by amino acid availability
(9). In the absence of changes in the rates of muscle protein
synthesis at the later part of the sleep period as well as the
lack of observed changes in the anabolic signaling pathway,
we propose that any observed change in whole body protein
balance was likely due to the postprandial effect of protein
ingestion (<4 h following ingestion) or that the improved whole
body protein balance was primarily driven by other organs
other than muscle. The former is partly supported by a recent
study in elderly individuals in which the authors investigated
the effect of a bolus vs. a pulse feeding pattern of amino acids
on muscle protein synthesis. They reported extended elevated
essential aminoacidemia in the absence of increased muscle
protein synthesis (32) which the authors attributed to the “muscle
full” state (a state describing the point at which stimulation
of muscle protein synthesis becomes refractory to the ongoing
availability of EAA).
The insulin response to the treatment and placebo beverages
displayed significantly different values at the 1 h time point
whereby the placebo ingestion resulted in a greater insulin
peak compared to the treatment group (Figure 4B). This is
not surprising given the increased maltodextrin content of the
placebo beverage (in order to provide isocaloric properties
between treatment and placebo groups). Furthermore, ingestion
of the placebo beverage also resulted in a higher glucose peak
compared to the protein group 1 h post ingestion. However,
despite the lower levels of maltodextrin in the treatment
group, plasma glucose levels in the treatment group failed to
return to basal levels in the morning (08:00) and therefore,
fasting plasma glucose remained higher relative to the control
group but no significant effect was observed for insulin. The
exact physiological significance of this response however is
not clear. Several studies have reported mixed observations
on measures of glucose handling in the morning following
either pre-bedtime or overnight nutrient provisions (27, 29,
33–35). In a study investigating the effect of providing a
pre-bed time protein or carbohydrate snack to overweight
sedentary women, the authors reported that plasma insulin
concentrations were negatively affected resulting in an increased
homeostatic model assessment of insulin resistance score
indicating an insulin resistant phenotype (33). In contrast,
introducing physical activity to the daily routine prevented
the negative responses in insulin (34). It seems therefore that
beyond the caloric content, the habitual physical activity status
of an individual is an important determinant regulating the
metabolic milieu following a pre-bedtime nutrient containing
snack. In addition, the overall body composition of an
individual may also further impact the results, as lean tissue
percentage may impact insulin sensitivity and/or glucose uptake,
something we were not able to control for in the present
work. However, one limitation in the current study which
prohibits us to conclude on the impact of pre-bed protein
ingestion on the subsequent morning glycemic control is the
absence of a fasting baseline glucose measure. This would
have enabled us to better compare fasting glycemia pre
and post-intervention.
Moreover, it is important that the circadian rhythm and
an integrative physiology approach should be considered
when planning pre-bedtime nutritional strategies aimed at
promoting specific health outcomes (36–39). For instance
controlling for sleep time as well as meal compositions 2–
3d prior to an intervention seems ever more important in
order to account for circadian rhythm disturbances which
may in turn impact the results. Whether these short term
benefits are translated into long term functional outcomes
remains to be seen. Nonetheless, in a recent study it was
shown that long-term pre-bedtime protein supplementation in
healthy young men resulted in greater gains in both, strength
and muscle mass following a 12 week progressive resistance
training program (27). However, what is not clear is whether
or not this effect was due to the timing of the protein
ingestion per se (before bed) or simply due to the extra 25 g
of protein ingested above that of the control group in a
24 h period.
In conclusion we show that the ingestion of a complete drink
containing 25 g of milk protein before sleep promotes whole
body protein balance in the morning compared to the ingestion
of an isocaloric, protein void pre-bed supplement in middle-
aged healthy men. Moreover, this effect was not related to a
stimulation in the rates of skeletal muscle protein synthesis in
the second part of the night, suggesting the observed anabolic
effect was likely a typical postprandial response observed in the
first half of the sleep period. Such nutritional strategies may be
implemented in order to attenuate age related losses of lean tissue
mass but other metabolic outcomes such as glucose handling
need to be incorporated and assessed to prevent any disturbances
to the metabolic milieu. Better understanding of the role of
chronobiology and how it is impacted by nutrition is of critical
significance in promoting long-term benefits of nutrient timing
interventions for the promotion and maintenance of health
and well-being.
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